school

Dr. Stan Shernan, MD, FAHA, FASE
Associate Professor
Harvard Medical School

Brigham and Women's Hospital
Department of Anesthesiology, Perioperative and Pain Medicine
75 Francis Street, CWN L1
Boston, MA 02115

Phone: (617) 732-8210
Fax: (617) 732-6798

sshernan@partners.org

MEET OUR TEAM
INVESTIGATORS:
Dr. Simon Body
Dr. Ronen Durst
Dr. Mahyar Heydarpour
Dr. Robert Levine
Dr. Christine Seidman
Dr. Jon Seidman
Dr. Stan Shernan
Dr. Susan Slaugenhaupt
STAFF:
Dr. Kujtim Bodinaku
Ms. Svetlana Gorbatov
Mr. James Gosnell
Ms. Adrienne Kicza
Ms. Barbara McDonough
Ms. Leah Rastiello
Ms. Elizabeth Sparks

Stanton K. Shernan, MD, is currently an Associate Professor of Anaesthesia at Harvard Medical School and the Director of Cardiac Anesthesia at the Brigham and Women’s Hospital. His academic interests have included education and research focused on the influence of perioperative echocardiography on perioperative clinical decision-making during cardiac surgery primarily involving valve procedures. In addition, Dr. Shernan has spent most of his career studying the mechanisms, treatment and risk factors including the potential role of genetic variation postoperative adverse outcomes including perioperative myocardial injury.

Education / Training
Medical School: Tufts University School of Medicine, Boston, MA
Residencies / Fellowships: Beth Israel Hospital, Boston, MA and Brigham & Women's Hospital, Boston, MA

Research focus:
Genetic variants on perioperative adverse clinical outcomes and the influence of transesophageal echocardiography on perioperative clinical decision-making

Representative Publications:
Perry T, Muehlschlegel J, Liu K, Fox A, Collard CD, Body S, Shernan S. Preoperative  C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting. (Anesthesiology 2009: In Press).

Liu KY, Muehlschlegel J, Perry T, Fox A, Collard CD, Body S, Shernan S. Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after CABG surgery. (Journal Cardiothorac and Vasc Surgery 2009: In press).

Muehlschlegel J, Perry T, Liu K, Nascimben L, Aranki S, D’Ambra M, Shernan S, Body S. Troponin is superior to other biomarkers and ECG for predicting myocardial injury after coronary artery bypass grafting. Eur Heart J 2009;30:1574-83.

Perry T, Muehlschlegel J, Liu K, Fox A, Collard C, Body S, Shernan S. C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass graft surgery. BMC Mede Genet 2009;10:38.

Sugeng L, Shernan S, Salgo I, Weinert L, Shook D,Raman J, Jeevanandam V, DuPontF,Settlemier S, Savord B, Mor-Av V, Fox J, Lang R. Real-Time 3D Transesophageal echocxardiography in valve disease:comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr 2008;12:1347-54.

BAV Genetics

email: contact@bav-genetics.org

Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115

[Welcome] [Who is  BAVgenetics?] [What does  BAVgenetics do?] [News and  Newsletters] [Privacy and  Disclaimers] [Contact]